Table 4 Anti-HCV seroprevalence in 1945–1994 birth cohort and risk group by age and sex

1945–1994 birth cohort

Males N (%)

-

588 (1.2)

1334 (1.6*)

1590 (1.9*^#)

1220 (1.8*^#)

491 (1.1*)

-

5223 (1.6*)

Females N (%)

-

946 (1.1)

1419 (1.1)

1219 (1.1)

675 (1.0)

374 (0.6^#)

-

4633 (1.0)

Total N (%)

-

1534 (1.1)

2753 (1.3)

2809 (1.5^#)

1895 (1.4)

865 (0.8)

-

9856 (1.3)

Risk group

Males N (%)

2 (7.1)

117 (26.2)

256 (35.0)

300 (35.2)

250 (33.4)

147 (30.1)

11 (21.6**)

1083 (32.3)

Females N (%)

4 (6.8)

159 (21.8)

288 (31.2)

248 (32.3)

149 (35.5)

153 (38.7)

3 (5.5)

1004 (29.9)

Total N (%)

6 (6.9)

276 (23.5)

544 (32.9)

548 (33.8)

399 (34.2)

300 (34.0)

14 (13.2)

2087 (31.1)

1945–1994 birth cohort and risk group

Males N (%)

2 (7.1)

705 (1.4)

1590 (1.8*)

1890 (2.3*^#)

1470 (2.2*^#)

638 (1.5*)

11 (21.6*)

6306 (1.9*)

Females N (%)

4 (6.8)

1105 (1.3)

1707 (1.3)

1467 (1.3)

824 (1.2)

527 (0.8)

3 (5.5)

5637 (1.2)

Total N (%)

6 (6.9)

1810 (1.3)

3297 (1.5)

3357 (1.7^#)

2294 (1.7^#)

1165 (1.1)

14 (13.2)

11,943 (1.5)